| Table of contents Rev. OFIL·ILAPHAR vol.31 n.1 Madrid Jan./Mar. 2021 Press Release | | | |
Editorials | | | | · The pharmaceutical profession should not feel alien to the euthanasia debate López Guzmán, J
| | | | · Manufacture of advanced therapy drugs in Hospital Pharmacy Services: shall we start? Poveda Andrés, JL; Valero García, S
| | | Originals | | | | · High-dose versus low-dose corticosteroid treatment strategy in patients hospitalised with COVID-19: effect on ICU admission rate García Muñoz, S; Santos San Segundo, M; Cebolla Beltrán, T; Boso Ribelles, V; Ferrando Piqueres, R
| | | | · Effectiveness and safety of a 50 mg/mL isoniazid syrup for pediatric use González Freire, L; Vázquez Blanco, S; Dávila Pousa, MC; Crespo-Diz, C
| | | | · Study of prescription-indication of methylphenidate in adults in a Healthcare Management Area Báez-Gutiérrez, N; Saborido-Cansino, MC; Sánchez-Pedrosa, A
| | | | · Automation in parenteral nutrition: quality control of the process before and after it`s implementation Barbosa, R; Capela, A; Sampaio, C; Fraga, S; Soares, T
| | | | · Vancomycin dosage in patients undergoing intermittent dialysis. Preparation of an initial dosage protocol Sáez-Torres de Vicente, M; López-Santamaría Donoso, J; Aumente Rubio, MD
| | | | · Effect of gastric-acid-reducing agents on the tyrosine kinasa inhibitors: contrasting information Gómez Lluch, MT; Proy Vega, B; Notario Dongil, C; Nieto-Sandoval Martín de la Sierra, P; Alañón Pardo, MM; Valenzuela Gámez, JC
| | | | · Global adherence to pharmacotherapeutic treatment in patients with multiple sclerosis Ballester Martínez, N; Rodríguez-Lucena, FJ; Cano Cuenca, N; Bonilla Peñarrubia, R; Devesa García, C; Candela Fajardo, A; Arroyo Domingo, E
| | | | · Graduated in Pharmaceutical Sciences: roles performed in clinical trials Saborido Martín, L; Sánchez Texidó, C; Álvarez Guerra, S; Hernández González, Z
| | | | · Acute kidney injury in the concomitant treatment of vancomycin with piperacillin/tazobactam Coutinho Cabral, A
| | | | · Pharmacokinetic monitoring of biological therapies in inflammatory bowel disease Alañón Pardo, MM; Roncero García-Escribano, O; Bernardos Martín, E; Legaz Huidobro, ML; Moreno López, MP; Valenzuela Gámez, JC
| | | | · Optimization of processes related to the inventory management of a hospital pharmacy using the Lean Six Sigma methodology Teiler, JS; Traverso, ML; Bustos Fierro, C
| | | | · Efavirenz plasma levels and dyslipidemia Aragonès Eroles, AM; Schoenenberger Arnaiz, JA; Cano Marrón, SM; Puig Ganau, T; Morales Portillo, A; Manonelles Fernández, A
| | | | · Access to medications in patients of the Seguro Integral de Salud (SIS) with diabetes mellitus and/or arterial hypertension in Peru Espinoza-Marchan, H; Alvarez-Risco, A; Solís-Tarazona, Z; Villegas-Chiguala, J; Zavaleta-Calderón, A; Astuvilca-Cupe, J; Espinoza-Huertas, R; Béjar-Cáceres, R
| | | Review | | | | · Topical hemostatic agents for surgical use Romero Crespo, I; Mora Herrera, C; Quirante Cremades, A; López Sánchez, P; Gaspar Carreño, M; Achau Muñoz, R
| | | Special Article | | | | · Undergraduate education in pharmacovigilance is effective to develop core competencies to assess drug safety by health professionals? Varallo, FR; Mastroianni, PC
| | | Clinical Cases | | | | · Chronic pruritus, diarrhea and polymedication: pharmacoterapeutic optimization based on pharmacist’ interventions Alzueta Isturiz, N; Echeverría Gorriti, A; Sanz Álvarez, L; Garjón Parra, J
| | | | · Systemic absorption of an oral vancomycin syrup for the treatment of Clostridium difficile infection Edo Peñarrocha, J; Belles Medall, MD; Garcia Muñoz, S; Ferrando Piqueres, R
| | | | · Bezlotoxumab in prevention of recurrent Clostridium difficile infection Rogado-Vegas, B; Sánchez-Gundín, J; Gómez-Gómez, D; Valero-Domínguez, M
| | | Letters to the Editor | | | | · Contribución del farmacéutico cubano al cumplimiento de las normas ISO en unidades de salud González Hernández, Z; Saborido Martín, L; Álvarez Guerra, S; Sánchez Texidó, C
| | | | · Equivalencia entre sales de calcio en España García Llopis, P; Hernàndez Lorente, E; Aparicio Rubio, C
| | | | · Secukinumab-associated inflammatory bowel disease? Rodríguez Ramallo, H; Báez Gutiérrez, N; Desongles Corrales, T
| | | | · Bevacizumab colirio en el tratamiento a largo plazo de la neovascularización corneal: a propósito de un caso López-Viñau López, T; Sáez-Torres de Vicente, M; Cuevas-Asencio, I; Morillas Teva, F
| | |
|